Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Schönrock-Nabulsi
R. Schönrock-Nabulsi
Myeloid leukemia
Mitoxantrone
Medicine
Internal medicine
Refractory
5
Papers
130
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Superiority of High-Dose over Intermediate-Dose Cytosine Arabinoside (AraC) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia (AML)
1998
W. Kern
C. Aul
G. Maschmeyer
R. Schönrock-Nabulsi
W.D. Ludwig
A. Bartholomäus
Peter Bettelheim
B. Wörmann
T. Büchner
W. Hiddemann
Show All
Source
Cite
Save
Citations (4)
Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia
1998
W Kern
C. Aul
G. Maschmeyer
R. Schönrock-Nabulsi
Andrea Kerkhoff
A. Grote-Metke
Hartmut Eimermacher
U. Kubica
B. Wörmann
T. Büchner
W. Hiddemann
Show All
Source
Cite
Save
Citations (0)
High-Dose Cytosine Arabinoside and Mitoxantrone (HAM) in the Treatment of Acute Leukemias: Results of Salvage and First Line Treatment
1992
Wolfgang Hiddemann
C. Aul
Georg Maschmeyer
W.D. Ludwig
H. Löffler
N. Nowrousian
R. Schönrock-Nabulsi
P. Bettelheim
Achim Heinecke
T. Büchner
Show All
Source
Cite
Save
Citations (1)
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.
1991
Seminars in Hematology
Wolfgang Hiddemann
C. Aul
Georg Maschmeyer
R. Schönrock-Nabulsi
Wolf-Dieter Ludwig
A. Bartholomäus
Bettelheim P
K. Becker
Leopold Balleisen
B. Lathan
Show All
Source
Cite
Save
Citations (35)
1